Gap (NYSE:GAP) Stock

GAP INC/THE

Gap retails apparel, accessories, and personal-care products under the Gap, Old Navy, Banana Republic, and Athleta brands. Old Navy generates more than half of Gap's sales. The firm also operates e-commerce sites, outlet stores, and specialty stores under various Gap names. Gap operates approximately 2,500 stores in North America, Europe, and Asia and franchises about 1,000 more in Asia, Europe, Latin America, and other regions. Gap was founded in 1969 and is based in San Francisco.

Gap Inc

GOLDEN APPLE OIL&GAS INC by Golden Apple Oil & Gas, Inc.

Golden Apple Oil and Gas Inc

FT Vest U.S. Equity Moderate Buffer ETF - April

Mizuho analyst Nitin Kumar initiates coverage on Diversified Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DEC#NYSE">DEC</a>) with a Outperform rating and announces Price Target of $23.

News

Price Target

Initiation

Analyst Ratings

Mizuho Initiates Coverage On Diversified Energy with Outperform Rating, Announces Price Target of $23

D. Boral Capital analyst Jason Kolbert maintains AVITA Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCEL#NASDAQ">RCEL</a>) with a Buy and maintains $22 price target.

RCEL

D. Boral Capital Maintains Buy on AVITA Medical, Maintains $22 Price Target

Needham analyst David Saxon reiterates CryoPort (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYRX#NASDAQ">CYRX</a>) with a Buy and maintains $11 price target.

Reiteration

CYRX

Needham Reiterates Buy on CryoPort, Maintains $11 Price Target

Mizuho analyst Anthony Petrone initiates coverage on Embecta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EMBC#NASDAQ">EMBC</a>) with a Neutral rating and announces Price Target of $15.

EMBC

Mizuho Initiates Coverage On Embecta with Neutral Rating, Announces Price Target of $15

RCAT: -11% &#x7C; <a href="https://www.benzinga.com//node/44731078">Red Cat Holdings shares are trading lower after the company announced a $30 million registered direct offering of common stock.</a>
&nbsp;
X: -15% &#x7C; <a href="https://www.benzinga.com//node/44724117">US Steel shares are trading lower after President Trump indicated he doesn't want to see the company go to Japan.</a>
&nbsp;
KTTA: 53% &#x7C; <a href="https://www.benzinga.com//node/44731294">Pasithea Therapeutics shares are trading higher after a Safety Review Committee recommended escalating to the next dose level of 30mg capsule in its ongoing Phase 1 trial of PAS-004 for advanced cancer.</a>

Movers

Trading Ideas

KTTA

RCAT

Market-Moving News for April 10th

Macro Economic Events

Economics

NEC Director Hassett On CNBC Said On Trump Tariff Pause: Everything Moved in Orderly Fashion; There Are Deals Close to Finish Line; Close to 20 Countries Making Offers

Mizuho analyst Anthony Petrone initiates coverage on Guardant Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GH#NASDAQ">GH</a>) with a Outperform rating and announces Price Target of $55.

Mizuho Initiates Coverage On Guardant Health with Outperform Rating, Announces Price Target of $55

Benchmark analyst David Williams reiterates Littelfuse (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LFUS#NASDAQ">LFUS</a>) from Hold to Hold.

LFUS

Benchmark Reiterates Hold on Littelfuseto Hold

D. Boral Capital analyst Jason Kolbert maintains Immunic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMUX#NASDAQ">IMUX</a>) with a Buy and maintains $17 price target.

IMUX

D. Boral Capital Maintains Buy on Immunic, Maintains $17 Price Target

Mizuho analyst Anthony Petrone initiates coverage on Senseonics Holdings (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SENS#AMEX">SENS</a>) with a Outperform rating and announces Price Target of $2.

SENS

Mizuho Initiates Coverage On Senseonics Holdings with Outperform Rating, Announces Price Target of $2

D. Boral Capital analyst Jason Kolbert maintains Anixa Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANIX#NASDAQ">ANIX</a>) with a Buy and maintains $10 price target.

ANIX

D. Boral Capital Maintains Buy on Anixa Biosciences, Maintains $10 Price Target

Needham analyst Gerald Pascarelli reiterates Constellation Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STZ#NYSE">STZ</a>) with a Buy and maintains $215 price target.

Needham Reiterates Buy on Constellation Brands, Maintains $215 Price Target

Mizuho analyst Anthony Petrone initiates coverage on Tandem Diabetes Care (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNDM#NASDAQ">TNDM</a>) with a Neutral rating and announces Price Target of $20.

TNDM

Mizuho Initiates Coverage On Tandem Diabetes Care with Neutral Rating, Announces Price Target of $20

Mizuho analyst Anthony Petrone initiates coverage on DexCom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXCM#NASDAQ">DXCM</a>) with a Outperform rating and announces Price Target of $85.

DXCM

Mizuho Initiates Coverage On DexCom with Outperform Rating, Announces Price Target of $85

Needham analyst Gil Blum reiterates Autolus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUTL#NASDAQ">AUTL</a>) with a Buy and maintains $10 price target.

AUTL

Needham Reiterates Buy on Autolus Therapeutics, Maintains $10 Price Target

DPRO

Draganfly Chosen By SafeLane Global As Its Preferred Unmanned Aerial Systems And Aerial Survey Provider

Mizuho analyst Anthony Petrone initiates coverage on Exact Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXAS#NASDAQ">EXAS</a>) with a Outperform rating and announces Price Target of $60.

EXAS

Mizuho Initiates Coverage On Exact Sciences with Outperform Rating, Announces Price Target of $60

Rosenblatt analyst Kevin Cassidy maintains Bitdeer Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTDR#NASDAQ">BTDR</a>) with a Buy and lowers the price target from $25 to $12.

BTDR

Rosenblatt Maintains Buy on Bitdeer Technologies, Lowers Price Target to $12

Needham analyst Ami Fadia reiterates Jazz Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAZZ#NASDAQ">JAZZ</a>) with a Buy and maintains $210 price target.

JAZZ

Needham Reiterates Buy on Jazz Pharmaceuticals, Maintains $210 Price Target

Mizuho initiates coverage on MannKind (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNKD#NASDAQ">MNKD</a>) with a Outperform rating and announces Price Target of $12.

MNKD

Mizuho Initiates Coverage On MannKind with Outperform Rating, Announces Price Target of $12

Press Releases

Gap Inc. to Report Third Quarter Fiscal 2024 Results on November 21

Dividends

Gap Inc. Announces Fourth Quarter Dividend

Earnings

Gap Inc. Reports Third Quarter Fiscal 2024 Results, Raises Full Year Outlook

Lexie Hull and Kate Martin Join Athleta's Power of She Collective

Gap Inc. to Report Fourth Quarter and Fiscal 2024 Results on March 6

Gap Inc. Announces 10 Percent Increase to First Quarter Dividend

Entertainment

General

Banana Republic Debuts Exclusive Capsule Collection Inspired by the HBO® Original Series The White Lotus

Gap Inc. Reports Fourth Quarter and Fiscal 2024 Results; Provides Fiscal 2025 Outlook

NYSE Content advisory: Pre-market update for March 7th

Old Navy Partners with RADAR to Elevate the Customer Experience with Plans for Phased Roll Out of its AI-Powered RFID Technology

American Eagle Outfitters, Inc. Common Stock

American Eagle Outfitters

Abercrombie & Fitch

Buckle

Boot Barn Holdings

Burlington Stores

Caleres

Citi Trends

Torrid Holdings

Foot Locker

Genesco

Guess

J.Jill

Lands' End

LightInTheBox Holding Co., Ltd. American Depositary Shares, each representing twelve ordinary shares

LightInTheBox Holding

MYT Netherlands Parent B.V. American Depositary Shares, each representing one Ordinary Share

Comments

Gap

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL